Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
D001645:Biguanides / Q000494:pharmacology; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology*; D004357:Drug Synergism; D005032:Ethylestrenol / Q000494:pharmacology; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000494:pharmacology; D010629:Phenformin / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D013739:Testosterone / Q000494:pharmacology
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013739:Testosterone; D009277:Nandrolone; D005032:Ethylestrenol; D010629:Phenformin